密苏里州立法者提出了2026项法案,以规范PBMs,旨在降低药物成本和保护药房。 Missouri lawmakers propose 2026 bills to regulate PBMs, aiming to lower drug costs and protect pharmacies.

密苏里州立法者为2026年会议提出了管理药房福利管理者的法案,旨在降低药品成本和保护当地药房。 Missouri lawmakers have introduced bills for the 2026 session to regulate pharmacy benefit managers (PBMs), aiming to lower drug costs and protect local pharmacies. 该立法由Sen.Jill Carter和John Hewkin Rep.John Hewkin赞助,将授权要求透明度,禁止支付超过药物成本的共同付费,确保公平报销药房费用,并为关键准入药房设立基金。 The legislation, sponsored by Sen. Jill Carter and Rep. John Hewkin, would mandate claims transparency, prohibit copays exceeding drug costs, ensure fair pharmacy reimbursements, and create a fund for critical access pharmacies. 支助者指出,特别是在农村地区,费用上涨、病人就诊问题和药房关闭问题,而工业团体则警告监管会减少弱势人口的就诊机会。 Supporters cite rising costs, patient access issues, and pharmacy closures, especially in rural areas, while industry groups warn regulations could reduce access for vulnerable populations. 这些法案遵循了其他各州的类似改革,以及最近对涉嫌操纵价格的PBM公司提起的诉讼。 The bills follow similar reforms in other states and recent lawsuits against PBMs over alleged price manipulation. 一项相关的联邦法案,即PBM FAIR法,试图对PBM规定信托义务,提高ERISA的透明度。 A related federal bill, the PBM FAIR Act, seeks to impose fiduciary duties on PBMs and improve transparency under ERISA.